Post Categories
Rezdiffra Gains Approval, Marks a New Chapter in Treating NASH (MASH) with Liver Scarring
November 4, 2024
The US Food and Drug Administration (FDA) has approved Rezdiffra™ (resmetirom), the first medication for treating patients with nonalcoholic steatohepatitis (NASH) with moderate to…
Exciting New Epilepsy Drug Reduces Seizures
October 30, 2024
Epilepsy affects as many as 50 million people worldwide, with a broad range of disease subtypes with limited treatment options. Fortunately, a new epilepsy…
Could Gene Therapy in Cows Slow Climate Change?
October 28, 2024
Despite the impact of companies like Impossible Foods, which markets plant-based imitation meat products, the demand for beef has never been higher. As of…
Weight Loss Drug Prescriptions Become More Accessible With Single-Dose Option
October 21, 2024
Eli Lilly has launched a new way for patients to access its popular weight loss drug, Zepbound® (tirzepatide). The company now offers single-dose vials…
Sizing Up Potential Medicare Costs of Covering Weight Loss Drugs for Heart Health
October 14, 2024
Medicare may soon face steeply increased prescription drug costs as it considers covering the popular weight loss drug, Wegovy® (semaglutide). Known for its ability…
Bispecific Antibody Drug Shows Cancer Treatment Potential
October 7, 2024
A new contender in the fight against lung cancer has emerged, with strong clinical trial results for ivonescimab, a bispecific antibody from partners Akeso…
Advancing CRISPR-Based Treatment for Rare Swelling Disease
September 30, 2024
Intellia Therapeutics, based in Cambridge, Massachusetts, reported promising results from the Phase II clinical trial of NTLA-2002, a CRISPR-based therapy targeting hereditary angioedema (HAE),…
Advancing Phase 3 Trials for ADC Cancer Therapies
September 25, 2024
Antibody-drug conjugates (ADCs) are being studied in various diseases, including cancer, autoimmune and infectious diseases. In cancer, ADCs are made up of a monoclonal…
Battling COVID in the Lab: Mini-Lungs Yield Insights and Potential Prevention Pathways
September 23, 2024
Over the past five years, scientists have slowly gained a better understanding of SARS-CoV-2, the virus responsible for the COVID-19 pandemic. Despite our knowledge…
New Cancer Treatment Modality Goes into Phase I
September 18, 2024
Prostate cancer is the second most common cancer in men worldwide, making the search for effective treatments an urgent imperative for the medical community….
Breaking Ground in Cancer Treatment: First T-Cell Therapy Approved for Solid Tumors
September 16, 2024
Tecelra®, the first engineered T-cell therapy for solid tumors, has received approval from the Food and Drug Administration (FDA) for advanced MAGE-A4+ synovial sarcoma…
Medicare Price Cuts Promise Relief to Seniors
September 9, 2024
In a historic move, the White House announced steep price reductions for ten prescription drugs under Medicare thanks to the Inflation Reduction Act (IRA)….
Backed Into a Corner: Few Interventions Work for Low Back Pain
April 28, 2025
Low back pain affects almost everyone at some point during their lifetime. Globally, it is the leading cause of years lived with disability, a…
There’s a New Bird Flu in Town
April 23, 2025
The highly pathogenic H5N1 virus, also known as avian flu or bird flu, continues to sweep through poultry farms in the United States. While…
Creatine’s Muscle Myth: New Study Deflates the Hype
April 21, 2025
Creatine has long been the darling of gym bros and supplement pros. Touted as a muscle-building powerhouse, it’s naturally produced by the liver, pancreas…
Linking a Rare Allergic Condition to Long-Lasting Hiccups
April 16, 2025
Hiccups always seem to strike at the least convenient time. Maybe you’re delivering an important presentation when you feel that telltale catch in your…
Researchers See Promise in First Pig-to-Human Liver Transplant
April 14, 2025
As the number of people in need of liver transplantation continues to grow, the supply of donor organs is failing to meet the need….
Slowing the Clock: Trial Delivers Hope in Delaying Alzheimer’s Disease
April 7, 2025
People with a rare genetic form of Alzheimer’s disease can begin to experience memory loss and dementia starting in their 30s, 40s and 50s….
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
